

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.67462222 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.67462222 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.54753645 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.54753645 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.16595991 |
| 6 | nuclear pore complex assembly (GO:0051292) | 5.10506767 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.99505791 |
| 8 | lysine catabolic process (GO:0006554) | 4.98268446 |
| 9 | lysine metabolic process (GO:0006553) | 4.98268446 |
| 10 | glyoxylate metabolic process (GO:0046487) | 4.93078234 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.90735685 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.71882575 |
| 13 | 2-oxoglutarate metabolic process (GO:0006103) | 4.63341933 |
| 14 | fatty acid transmembrane transport (GO:1902001) | 4.59640364 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.57109476 |
| 16 | carnitine shuttle (GO:0006853) | 4.54745674 |
| 17 | nuclear pore organization (GO:0006999) | 4.50110443 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 4.38848704 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.35586684 |
| 20 | tryptophan catabolic process (GO:0006569) | 4.31636032 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 4.31636032 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 4.31636032 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 4.31599450 |
| 24 | regulation of triglyceride catabolic process (GO:0010896) | 4.31285462 |
| 25 | urea cycle (GO:0000050) | 4.23539662 |
| 26 | urea metabolic process (GO:0019627) | 4.23539662 |
| 27 | fatty acid beta-oxidation (GO:0006635) | 4.21500704 |
| 28 | amino-acid betaine metabolic process (GO:0006577) | 4.17411547 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.16254310 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.15952469 |
| 31 | valine metabolic process (GO:0006573) | 4.14552358 |
| 32 | cysteine metabolic process (GO:0006534) | 4.11006718 |
| 33 | acetyl-CoA metabolic process (GO:0006084) | 4.08810810 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.06582622 |
| 35 | aspartate family amino acid catabolic process (GO:0009068) | 4.04510879 |
| 36 | complement activation, alternative pathway (GO:0006957) | 4.01583806 |
| 37 | regulation of protein activation cascade (GO:2000257) | 3.94836378 |
| 38 | muscle filament sliding (GO:0030049) | 3.94612079 |
| 39 | actin-myosin filament sliding (GO:0033275) | 3.94612079 |
| 40 | ketone body metabolic process (GO:1902224) | 3.94601851 |
| 41 | fatty acid oxidation (GO:0019395) | 3.94351453 |
| 42 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.94296540 |
| 43 | short-chain fatty acid metabolic process (GO:0046459) | 3.92911538 |
| 44 | formation of translation preinitiation complex (GO:0001731) | 3.92285375 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 3.90732557 |
| 46 | tyrosine metabolic process (GO:0006570) | 3.89352425 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 3.89274430 |
| 48 | protein carboxylation (GO:0018214) | 3.88825077 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.88825077 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 3.88811290 |
| 51 | lipid oxidation (GO:0034440) | 3.88354904 |
| 52 | regulation of fibrinolysis (GO:0051917) | 3.87666776 |
| 53 | fatty acid catabolic process (GO:0009062) | 3.85657677 |
| 54 | tricarboxylic acid cycle (GO:0006099) | 3.85460095 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 3.83361107 |
| 56 | reverse cholesterol transport (GO:0043691) | 3.79288913 |
| 57 | DNA unwinding involved in DNA replication (GO:0006268) | 3.78828254 |
| 58 | ribosome assembly (GO:0042255) | 3.78300391 |
| 59 | acylglycerol homeostasis (GO:0055090) | 3.77901284 |
| 60 | triglyceride homeostasis (GO:0070328) | 3.77901284 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77336452 |
| 62 | homocysteine metabolic process (GO:0050667) | 3.73096507 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.72674546 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 3.72674546 |
| 65 | macromolecular complex remodeling (GO:0034367) | 3.72674546 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 3.72364163 |
| 67 | oxaloacetate metabolic process (GO:0006107) | 3.72313786 |
| 68 | regulation of complement activation (GO:0030449) | 3.70458333 |
| 69 | pore complex assembly (GO:0046931) | 3.69058729 |
| 70 | bile acid metabolic process (GO:0008206) | 3.68888791 |
| 71 | branched-chain amino acid catabolic process (GO:0009083) | 3.68882897 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 3.67864209 |
| 73 | positive regulation of fatty acid oxidation (GO:0046321) | 3.67150484 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.66383790 |
| 75 | regulation of sequestering of triglyceride (GO:0010889) | 3.63482544 |
| 76 | regulation of cholesterol esterification (GO:0010872) | 3.61932608 |
| 77 | mitotic chromosome condensation (GO:0007076) | 3.60484897 |
| 78 | carnitine metabolic process (GO:0009437) | 3.59628742 |
| 79 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.58702818 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.57577550 |
| 81 | protein localization to chromosome, centromeric region (GO:0071459) | 3.56269518 |
| 82 | phospholipid homeostasis (GO:0055091) | 3.55067052 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.54324814 |
| 84 | coenzyme catabolic process (GO:0009109) | 3.52241340 |
| 85 | regulation of skeletal muscle contraction (GO:0014819) | 3.52043241 |
| 86 | branched-chain amino acid metabolic process (GO:0009081) | 3.51905334 |
| 87 | DNA strand elongation (GO:0022616) | 3.51789090 |
| 88 | neutrophil activation involved in immune response (GO:0002283) | 3.50664120 |
| 89 | ethanol oxidation (GO:0006069) | 3.49636076 |
| 90 | organic acid catabolic process (GO:0016054) | 3.48989720 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.48989720 |
| 92 | tricarboxylic acid metabolic process (GO:0072350) | 3.48973021 |
| 93 | glutamate metabolic process (GO:0006536) | 3.48152554 |
| 94 | succinate metabolic process (GO:0006105) | 3.47841556 |
| 95 | carnitine transmembrane transport (GO:1902603) | 3.46391630 |
| 96 | regulation of fatty acid oxidation (GO:0046320) | 3.46237758 |
| 97 | cellular glucuronidation (GO:0052695) | 3.45637040 |
| 98 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.44280600 |
| 99 | phospholipid efflux (GO:0033700) | 3.43335916 |
| 100 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.43219559 |
| 101 | protein localization to kinetochore (GO:0034501) | 3.38209351 |
| 102 | biotin metabolic process (GO:0006768) | 3.34122228 |
| 103 | carnitine transport (GO:0015879) | 3.34097639 |
| 104 | amino-acid betaine transport (GO:0015838) | 3.34097639 |
| 105 | negative regulation of cholesterol transport (GO:0032375) | 3.33266282 |
| 106 | negative regulation of sterol transport (GO:0032372) | 3.33266282 |
| 107 | fatty acid homeostasis (GO:0055089) | 3.30743255 |
| 108 | mitotic metaphase plate congression (GO:0007080) | 3.25482827 |
| 109 | actin-mediated cell contraction (GO:0070252) | 3.22348583 |
| 110 | glycine metabolic process (GO:0006544) | 3.20072225 |
| 111 | 4-hydroxyproline metabolic process (GO:0019471) | 3.19908257 |
| 112 | regulation of cholesterol homeostasis (GO:2000188) | 3.19125888 |
| 113 | mitotic sister chromatid segregation (GO:0000070) | 3.18747347 |
| 114 | arginine metabolic process (GO:0006525) | 3.17720840 |
| 115 | telomere maintenance via recombination (GO:0000722) | 3.16217439 |
| 116 | NADH metabolic process (GO:0006734) | 3.15019567 |
| 117 | mitotic recombination (GO:0006312) | 3.06439683 |
| 118 | mitotic nuclear envelope disassembly (GO:0007077) | 3.04212677 |
| 119 | sister chromatid segregation (GO:0000819) | 3.03480732 |
| 120 | establishment of integrated proviral latency (GO:0075713) | 3.02134557 |
| 121 | ribosomal large subunit biogenesis (GO:0042273) | 2.97937408 |
| 122 | pinocytosis (GO:0006907) | 2.97074079 |
| 123 | DNA replication initiation (GO:0006270) | 2.95206425 |
| 124 | purine nucleobase biosynthetic process (GO:0009113) | 2.92065430 |
| 125 | CENP-A containing nucleosome assembly (GO:0034080) | 2.88716255 |
| 126 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.88662169 |
| 127 | mitotic sister chromatid cohesion (GO:0007064) | 2.86509151 |
| 128 | IMP biosynthetic process (GO:0006188) | 2.86352160 |
| 129 | membrane disassembly (GO:0030397) | 2.85071027 |
| 130 | nuclear envelope disassembly (GO:0051081) | 2.85071027 |
| 131 | establishment of chromosome localization (GO:0051303) | 2.78725319 |
| 132 | metaphase plate congression (GO:0051310) | 2.77824737 |
| 133 | DNA topological change (GO:0006265) | 2.74285056 |
| 134 | cellular protein complex localization (GO:0034629) | 2.73644222 |
| 135 | nucleobase biosynthetic process (GO:0046112) | 2.71719543 |
| 136 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.71190849 |
| 137 | response to peptidoglycan (GO:0032494) | 2.67607110 |
| 138 | ribosomal small subunit assembly (GO:0000028) | 2.66170191 |
| 139 | chromatin remodeling at centromere (GO:0031055) | 2.64314090 |
| 140 | regulation of chromosome segregation (GO:0051983) | 2.63492615 |
| 141 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.61807219 |
| 142 | DNA replication checkpoint (GO:0000076) | 2.60917590 |
| 143 | mitotic spindle checkpoint (GO:0071174) | 2.60863659 |
| 144 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.60696002 |
| 145 | non-recombinational repair (GO:0000726) | 2.60696002 |
| 146 | negative regulation of chromosome segregation (GO:0051985) | 2.59077709 |
| 147 | spindle checkpoint (GO:0031577) | 2.58577729 |
| 148 | mitotic spindle assembly checkpoint (GO:0007094) | 2.57735640 |
| 149 | IMP metabolic process (GO:0046040) | 2.57662654 |
| 150 | positive regulation of chromosome segregation (GO:0051984) | 2.57049815 |
| 151 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.56811376 |
| 152 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.56811376 |
| 153 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.56811376 |
| 154 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.56811376 |
| 155 | negative regulation of sister chromatid segregation (GO:0033046) | 2.56811376 |
| 156 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.56055343 |
| 157 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.55932584 |
| 158 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.55932584 |
| 159 | spindle assembly checkpoint (GO:0071173) | 2.55790215 |
| 160 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.54912660 |
| 161 | negative regulation of DNA repair (GO:0045738) | 2.53526726 |
| 162 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.53402778 |
| 163 | regulation of centriole replication (GO:0046599) | 2.51746901 |
| 164 | protein complex localization (GO:0031503) | 2.50824137 |
| 165 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.45881797 |
| 166 | negative regulation of ligase activity (GO:0051352) | 2.45881797 |
| 167 | DNA duplex unwinding (GO:0032508) | 2.45863232 |
| 168 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.45233773 |
| 169 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.45233773 |
| 170 | regulation of sister chromatid segregation (GO:0033045) | 2.45233773 |
| 171 | proteasome assembly (GO:0043248) | 2.44648576 |
| 172 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.44636115 |
| 173 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.44555106 |
| 174 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.42894987 |
| 175 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.40748176 |
| 176 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.40009647 |
| 177 | DNA replication-independent nucleosome organization (GO:0034724) | 2.40009647 |
| 178 | regulation of sister chromatid cohesion (GO:0007063) | 2.39346361 |
| 179 | viral mRNA export from host cell nucleus (GO:0046784) | 2.37702017 |
| 180 | ribosome biogenesis (GO:0042254) | 2.37385819 |
| 181 | DNA geometric change (GO:0032392) | 2.37191526 |
| 182 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.36773875 |
| 183 | detection of other organism (GO:0098543) | 2.35045019 |
| 184 | establishment of viral latency (GO:0019043) | 2.33726924 |
| 185 | rRNA methylation (GO:0031167) | 2.32930088 |
| 186 | DNA ligation (GO:0006266) | 2.32605788 |
| 187 | tRNA aminoacylation for protein translation (GO:0006418) | 2.30441006 |
| 188 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.28778761 |
| 189 | cell cycle G1/S phase transition (GO:0044843) | 2.28778761 |
| 190 | regulation of translational termination (GO:0006449) | 2.28375792 |
| 191 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.27331739 |
| 192 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.27331739 |
| 193 | modulation by symbiont of host immune response (GO:0052553) | 2.27331739 |
| 194 | positive regulation by symbiont of host defense response (GO:0052509) | 2.27331739 |
| 195 | modulation by symbiont of host defense response (GO:0052031) | 2.27331739 |
| 196 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.27331739 |
| 197 | telomere maintenance via telomere lengthening (GO:0010833) | 2.26413432 |
| 198 | maturation of SSU-rRNA (GO:0030490) | 2.26159237 |
| 199 | rRNA modification (GO:0000154) | 2.25715187 |
| 200 | protein export from nucleus (GO:0006611) | 2.25540741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.75280890 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.58195682 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.95622639 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.18185059 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.45566539 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.67266160 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.43474858 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.73242091 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.70152287 |
| 10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.67939381 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.34598941 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.28509077 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.28300966 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15970338 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79741115 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.73411789 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.66369189 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.65135296 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.61667923 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.58558492 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.55337457 |
| 22 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.52209875 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.24186497 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18074858 |
| 25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.16939873 |
| 26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.16353453 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.14901635 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.10699982 |
| 29 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06323176 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.05309550 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04973708 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00369246 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0995338 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94625750 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91798338 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88943882 |
| 37 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87389988 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86109938 |
| 39 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.84890143 |
| 40 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.84043777 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82403536 |
| 42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.81299755 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81173502 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.73822297 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73303123 |
| 46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72631219 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72479595 |
| 48 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.71917362 |
| 49 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.71282161 |
| 50 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.68006565 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67237080 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66930923 |
| 53 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66664487 |
| 54 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.63975062 |
| 55 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.63661913 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.62726095 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59195510 |
| 58 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.58812105 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57701168 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.56457054 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55431039 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.54318467 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53121889 |
| 64 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52559062 |
| 65 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.50091254 |
| 66 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47481118 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46765860 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46347013 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.45694143 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.45694143 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43808722 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 1.43458386 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42077001 |
| 74 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41855268 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40551055 |
| 76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39826978 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.37488002 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36652739 |
| 79 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.33137927 |
| 80 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.33006411 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.30598643 |
| 82 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.29311628 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25726729 |
| 84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.25218176 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22902902 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22586168 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21899451 |
| 88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20776196 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20554272 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 1.18930321 |
| 91 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17967192 |
| 92 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17312330 |
| 93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17175719 |
| 94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17086354 |
| 95 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.16277246 |
| 96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14221978 |
| 97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13773403 |
| 98 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12787329 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 1.12558227 |
| 100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12225085 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11129905 |
| 102 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10487365 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10381164 |
| 104 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10050224 |
| 105 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08861199 |
| 106 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08497119 |
| 107 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07568502 |
| 108 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06781419 |
| 109 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05788643 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05705414 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05086686 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04756677 |
| 113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04634819 |
| 114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03784113 |
| 115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03336347 |
| 116 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99362377 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99355927 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99354417 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98669248 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97739739 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97343132 |
| 122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95404622 |
| 123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95404622 |
| 124 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95188870 |
| 125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94529408 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94419952 |
| 127 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94299811 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93487524 |
| 129 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93314206 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93299933 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91477731 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89537287 |
| 133 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89300042 |
| 134 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.88735212 |
| 135 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88691053 |
| 136 | MAF_26560356_Chip-Seq_TH1_Human | 0.88236054 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83919143 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82761001 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81601779 |
| 140 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81176051 |
| 141 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81127325 |
| 142 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80369842 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80204447 |
| 144 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79556986 |
| 145 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78031361 |
| 146 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.75701025 |
| 147 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.75359656 |
| 148 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74950113 |
| 149 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.73991344 |
| 150 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71568254 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70928447 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70928447 |
| 153 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69439140 |
| 154 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68362050 |
| 155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68351257 |
| 156 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67159288 |
| 157 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.66243365 |
| 158 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.66136147 |
| 159 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65707536 |
| 160 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.64988012 |
| 161 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.64868186 |
| 162 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.64346001 |
| 163 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62252327 |
| 164 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.62221495 |
| 165 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61818331 |
| 166 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.61606680 |
| 167 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61005240 |
| 168 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.60685930 |
| 169 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60493514 |
| 170 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.60354742 |
| 171 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59874966 |
| 172 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59647052 |
| 173 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.59075413 |
| 174 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.58980534 |
| 175 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57943045 |
| 176 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57456081 |
| 177 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.57218903 |
| 178 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57048850 |
| 179 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.56895897 |
| 180 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.56356312 |
| 181 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.55628615 |
| 182 | ATF3_27146783_Chip-Seq_COLON_Human | 0.55546626 |
| 183 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.54852493 |
| 184 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54829634 |
| 185 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.54081067 |
| 186 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.53741732 |
| 187 | P68_20966046_ChIP-Seq_HELA_Human | 0.53346545 |
| 188 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.52755895 |
| 189 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52311675 |
| 190 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.52215991 |
| 191 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.52119533 |
| 192 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.51833937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.08976945 |
| 2 | MP0005360_urolithiasis | 5.37127311 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.60918686 |
| 4 | MP0005365_abnormal_bile_salt | 4.50769783 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.67337074 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.63726285 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.50827139 |
| 8 | MP0003646_muscle_fatigue | 3.37049753 |
| 9 | MP0010094_abnormal_chromosome_stability | 3.08014543 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.02330093 |
| 11 | MP0008057_abnormal_DNA_replication | 2.95909489 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.92518852 |
| 13 | MP0000749_muscle_degeneration | 2.81580034 |
| 14 | MP0003252_abnormal_bile_duct | 2.75740256 |
| 15 | MP0000751_myopathy | 2.70172433 |
| 16 | MP0004130_abnormal_muscle_cell | 2.68531087 |
| 17 | MP0009840_abnormal_foam_cell | 2.64289976 |
| 18 | MP0002796_impaired_skin_barrier | 2.61533051 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.57046984 |
| 20 | MP0005083_abnormal_biliary_tract | 2.49691113 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.48895429 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.48810937 |
| 23 | MP0003693_abnormal_embryo_hatching | 2.47938771 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.43837362 |
| 25 | MP0005332_abnormal_amino_acid | 2.34042920 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 2.29344584 |
| 27 | MP0003077_abnormal_cell_cycle | 2.28565857 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 2.28331453 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 2.15578618 |
| 30 | MP0004084_abnormal_cardiac_muscle | 2.15410016 |
| 31 | MP0003195_calcinosis | 2.12202633 |
| 32 | MP0005670_abnormal_white_adipose | 1.98223571 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.94892619 |
| 34 | MP0002269_muscular_atrophy | 1.93749196 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.91251843 |
| 36 | MP0008260_abnormal_autophagy | 1.88217563 |
| 37 | MP0003941_abnormal_skin_development | 1.88148573 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.87552676 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.85446840 |
| 40 | MP0004087_abnormal_muscle_fiber | 1.84737261 |
| 41 | MP0008058_abnormal_DNA_repair | 1.84383833 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.83818885 |
| 43 | MP0005330_cardiomyopathy | 1.82991622 |
| 44 | MP0005501_abnormal_skin_physiology | 1.79071966 |
| 45 | MP0000747_muscle_weakness | 1.78205816 |
| 46 | MP0000609_abnormal_liver_physiology | 1.74490311 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.74241325 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.72680274 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.72151011 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.71667756 |
| 51 | MP0005620_abnormal_muscle_contractility | 1.68914113 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.61764892 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.59998532 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59208199 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.57366712 |
| 56 | MP0010307_abnormal_tumor_latency | 1.54624438 |
| 57 | MP0008932_abnormal_embryonic_tissue | 1.54578849 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.53867853 |
| 59 | MP0002006_tumorigenesis | 1.52298424 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.52243702 |
| 61 | MP0001853_heart_inflammation | 1.50615214 |
| 62 | MP0003828_pulmonary_edema | 1.50607982 |
| 63 | MP0003786_premature_aging | 1.46220949 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.44296628 |
| 65 | MP0000759_abnormal_skeletal_muscle | 1.43507621 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.40919100 |
| 67 | MP0002971_abnormal_brown_adipose | 1.38733060 |
| 68 | MP0001730_embryonic_growth_arrest | 1.38348801 |
| 69 | MP0001216_abnormal_epidermal_layer | 1.37938832 |
| 70 | MP0000750_abnormal_muscle_regeneration | 1.37165834 |
| 71 | MP0004947_skin_inflammation | 1.36201225 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.34166526 |
| 73 | MP0002972_abnormal_cardiac_muscle | 1.34133958 |
| 74 | MP0002009_preneoplasia | 1.33671708 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.33419096 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.32963233 |
| 77 | MP0005369_muscle_phenotype | 1.29855253 |
| 78 | MP0002332_abnormal_exercise_endurance | 1.28310176 |
| 79 | MP0008775_abnormal_heart_ventricle | 1.27694792 |
| 80 | MP0002060_abnormal_skin_morphology | 1.27382147 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.26323738 |
| 82 | MP0003300_gastrointestinal_ulcer | 1.25902617 |
| 83 | MP0000858_altered_metastatic_potential | 1.25393256 |
| 84 | MP0001764_abnormal_homeostasis | 1.24717809 |
| 85 | MP0002419_abnormal_innate_immunity | 1.24699529 |
| 86 | MP0002398_abnormal_bone_marrow | 1.22713613 |
| 87 | MP0003724_increased_susceptibility_to | 1.21560337 |
| 88 | MP0000490_abnormal_crypts_of | 1.20452241 |
| 89 | MP0004019_abnormal_vitamin_homeostasis | 1.19714641 |
| 90 | MP0002019_abnormal_tumor_incidence | 1.18910934 |
| 91 | MP0005385_cardiovascular_system_phenoty | 1.17197327 |
| 92 | MP0001544_abnormal_cardiovascular_syste | 1.17197327 |
| 93 | MP0003436_decreased_susceptibility_to | 1.15516725 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 1.14672239 |
| 95 | MP0001800_abnormal_humoral_immune | 1.14308419 |
| 96 | MP0002452_abnormal_antigen_presenting | 1.14238688 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 1.13927787 |
| 98 | MP0005451_abnormal_body_composition | 1.13655637 |
| 99 | MP0002132_abnormal_respiratory_system | 1.12842631 |
| 100 | MP0004233_abnormal_muscle_weight | 1.11663007 |
| 101 | MP0005266_abnormal_metabolism | 1.10497893 |
| 102 | MP0000313_abnormal_cell_death | 1.10249268 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09500285 |
| 104 | MP0010630_abnormal_cardiac_muscle | 1.09432263 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 1.08771264 |
| 106 | MP0001697_abnormal_embryo_size | 1.08390949 |
| 107 | MP0001672_abnormal_embryogenesis/_devel | 1.08254613 |
| 108 | MP0005380_embryogenesis_phenotype | 1.08254613 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 1.07699436 |
| 110 | MP0009785_altered_susceptibility_to | 1.07430185 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 1.07420835 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 1.07358761 |
| 113 | MP0005000_abnormal_immune_tolerance | 1.06756435 |
| 114 | MP0002722_abnormal_immune_system | 1.06389837 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 1.06049839 |
| 116 | MP0003186_abnormal_redox_activity | 1.05399694 |
| 117 | MP0003984_embryonic_growth_retardation | 1.04619558 |
| 118 | MP0002420_abnormal_adaptive_immunity | 1.04524485 |
| 119 | MP0001819_abnormal_immune_cell | 1.04296181 |
| 120 | MP0002080_prenatal_lethality | 1.03734414 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 1.03379932 |
| 122 | MP0003868_abnormal_feces_composition | 1.02668974 |
| 123 | MP0000703_abnormal_thymus_morphology | 1.02523536 |
| 124 | MP0005025_abnormal_response_to | 1.02418671 |
| 125 | MP0003448_altered_tumor_morphology | 1.02391786 |
| 126 | MP0009697_abnormal_copulation | 1.01895698 |
| 127 | MP0009643_abnormal_urine_homeostasis | 1.01338194 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 1.01282922 |
| 129 | MP0002086_abnormal_extraembryonic_tissu | 1.00967233 |
| 130 | MP0002723_abnormal_immune_serum | 1.00692063 |
| 131 | MP0005334_abnormal_fat_pad | 1.00615108 |
| 132 | MP0006138_congestive_heart_failure | 0.98150347 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.98017742 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.97603902 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.97603902 |
| 136 | MP0003303_peritoneal_inflammation | 0.97272805 |
| 137 | MP0000689_abnormal_spleen_morphology | 0.96655147 |
| 138 | MP0002429_abnormal_blood_cell | 0.96530028 |
| 139 | MP0005375_adipose_tissue_phenotype | 0.96380770 |
| 140 | MP0000685_abnormal_immune_system | 0.95020914 |
| 141 | MP0005535_abnormal_body_temperature | 0.94888376 |
| 142 | MP0000358_abnormal_cell_content/ | 0.94620753 |
| 143 | MP0003011_delayed_dark_adaptation | 0.91961135 |
| 144 | MP0005671_abnormal_response_to | 0.91006222 |
| 145 | MP0000716_abnormal_immune_system | 0.90546021 |
| 146 | MP0010155_abnormal_intestine_physiology | 0.90444102 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.90101584 |
| 148 | MP0000598_abnormal_liver_morphology | 0.89684027 |
| 149 | MP0005621_abnormal_cell_physiology | 0.89356012 |
| 150 | MP0002405_respiratory_system_inflammati | 0.89016915 |
| 151 | MP0001191_abnormal_skin_condition | 0.88968844 |
| 152 | MP0010368_abnormal_lymphatic_system | 0.86079776 |
| 153 | MP0000377_abnormal_hair_follicle | 0.85652290 |
| 154 | MP0001851_eye_inflammation | 0.82485573 |
| 155 | MP0009931_abnormal_skin_appearance | 0.81186935 |
| 156 | MP0005023_abnormal_wound_healing | 0.81024221 |
| 157 | MP0005376_homeostasis/metabolism_phenot | 0.80658134 |
| 158 | MP0000604_amyloidosis | 0.79902677 |
| 159 | MP0003137_abnormal_impulse_conducting | 0.79433689 |
| 160 | MP0004484_altered_response_of | 0.71884916 |
| 161 | MP0003329_amyloid_beta_deposits | 0.71819994 |
| 162 | MP0009642_abnormal_blood_homeostasis | 0.70282708 |
| 163 | MP0000230_abnormal_systemic_arterial | 0.69532123 |
| 164 | MP0005636_abnormal_mineral_homeostasis | 0.68091677 |
| 165 | MP0002254_reproductive_system_inflammat | 0.68062566 |
| 166 | MP0002108_abnormal_muscle_morphology | 0.67456086 |
| 167 | MP0009115_abnormal_fat_cell | 0.66380142 |
| 168 | MP0002822_catalepsy | 0.65305894 |
| 169 | MP0005448_abnormal_energy_balance | 0.62680110 |
| 170 | MP0005647_abnormal_sex_gland | 0.61910082 |
| 171 | MP0004085_abnormal_heartbeat | 0.61204123 |
| 172 | MP0008438_abnormal_cutaneous_collagen | 0.61053101 |
| 173 | MP0009763_increased_sensitivity_to | 0.60567049 |
| 174 | MP0002127_abnormal_cardiovascular_syste | 0.60419360 |
| 175 | MP0000013_abnormal_adipose_tissue | 0.59384894 |
| 176 | MP0009384_cardiac_valve_regurgitation | 0.58587960 |
| 177 | MP0002970_abnormal_white_adipose | 0.55934747 |
| 178 | MP0004043_abnormal_pH_regulation | 0.55864417 |
| 179 | MP0001661_extended_life_span | 0.55187382 |
| 180 | MP0009764_decreased_sensitivity_to | 0.54209860 |
| 181 | MP0003959_abnormal_lean_body | 0.53009831 |
| 182 | MP0001756_abnormal_urination | 0.52498814 |
| 183 | MP0005408_hypopigmentation | 0.51144908 |
| 184 | MP0008469_abnormal_protein_level | 0.50474651 |
| 185 | MP0002909_abnormal_adrenal_gland | 0.49709211 |
| 186 | MP0003950_abnormal_plasma_membrane | 0.48324162 |
| 187 | MP0000003_abnormal_adipose_tissue | 0.46343152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.37425057 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.35852213 |
| 3 | Myoglobinuria (HP:0002913) | 5.02593255 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.69517510 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.55559121 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.55306513 |
| 7 | Xanthomatosis (HP:0000991) | 4.46525028 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.32265308 |
| 9 | Rhabdomyolysis (HP:0003201) | 4.10871321 |
| 10 | Ketosis (HP:0001946) | 4.02295381 |
| 11 | Hyperammonemia (HP:0001987) | 3.99423380 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.96921628 |
| 13 | Hypolipoproteinemia (HP:0010981) | 3.88726336 |
| 14 | Hypoglycemic coma (HP:0001325) | 3.88507552 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 3.85564066 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.80301215 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.66258510 |
| 18 | Hyperglycinuria (HP:0003108) | 3.61798418 |
| 19 | Muscle fiber inclusion bodies (HP:0100299) | 3.60679849 |
| 20 | Abnormality of nail color (HP:0100643) | 3.59797833 |
| 21 | Ketoacidosis (HP:0001993) | 3.58790109 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 3.58444153 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 3.58345821 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.49364207 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48927736 |
| 26 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.48437331 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.42166593 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.42166593 |
| 29 | Complement deficiency (HP:0004431) | 3.33577415 |
| 30 | Hyperglycinemia (HP:0002154) | 3.30255592 |
| 31 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.26437204 |
| 32 | Type 1 muscle fiber predominance (HP:0003803) | 3.21243518 |
| 33 | Muscle stiffness (HP:0003552) | 3.15484593 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.14917851 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 3.11352713 |
| 36 | Nemaline bodies (HP:0003798) | 3.11230940 |
| 37 | Chromsome breakage (HP:0040012) | 3.09709667 |
| 38 | Sudden death (HP:0001699) | 3.00812205 |
| 39 | Epidermoid cyst (HP:0200040) | 2.97343178 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.94600962 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.92356048 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.90857431 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.90857431 |
| 44 | Cholecystitis (HP:0001082) | 2.90236552 |
| 45 | Abnormal gallbladder physiology (HP:0012438) | 2.90236552 |
| 46 | Cholelithiasis (HP:0001081) | 2.89853649 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.88047582 |
| 48 | Abnormal gallbladder morphology (HP:0012437) | 2.77784852 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.77190910 |
| 50 | Cerebral edema (HP:0002181) | 2.76650566 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.74590585 |
| 52 | Distal arthrogryposis (HP:0005684) | 2.72494765 |
| 53 | Difficulty running (HP:0009046) | 2.72386802 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.72382800 |
| 55 | Oral leukoplakia (HP:0002745) | 2.71847118 |
| 56 | Increased connective tissue (HP:0009025) | 2.68319635 |
| 57 | EMG: myopathic abnormalities (HP:0003458) | 2.67704181 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.66758624 |
| 59 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66572684 |
| 60 | Onycholysis (HP:0001806) | 2.65959839 |
| 61 | Metabolic acidosis (HP:0001942) | 2.63665094 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.62442019 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.57245193 |
| 64 | Gout (HP:0001997) | 2.56751134 |
| 65 | Abnormality of the calf musculature (HP:0001430) | 2.53378996 |
| 66 | Recurrent viral infections (HP:0004429) | 2.53012956 |
| 67 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.51507975 |
| 68 | Joint hemorrhage (HP:0005261) | 2.51187617 |
| 69 | Skin nodule (HP:0200036) | 2.49911367 |
| 70 | Increased IgE level (HP:0003212) | 2.48312628 |
| 71 | B lymphocytopenia (HP:0010976) | 2.45604578 |
| 72 | Lethargy (HP:0001254) | 2.43844562 |
| 73 | Palpitations (HP:0001962) | 2.42722915 |
| 74 | Fat malabsorption (HP:0002630) | 2.42405764 |
| 75 | Abnormality of serum amino acid levels (HP:0003112) | 2.41397586 |
| 76 | Hypercholesterolemia (HP:0003124) | 2.40672470 |
| 77 | Myelodysplasia (HP:0002863) | 2.39722049 |
| 78 | Abnormality of the intrinsic pathway (HP:0010989) | 2.38712670 |
| 79 | Ventricular tachycardia (HP:0004756) | 2.37116672 |
| 80 | Hyperbilirubinemia (HP:0002904) | 2.37029013 |
| 81 | Abnormality of the preputium (HP:0100587) | 2.34359433 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 2.33413174 |
| 83 | Subaortic stenosis (HP:0001682) | 2.32877453 |
| 84 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.32877453 |
| 85 | Myotonia (HP:0002486) | 2.31830935 |
| 86 | Late onset (HP:0003584) | 2.28520916 |
| 87 | Palmar hyperkeratosis (HP:0010765) | 2.28411094 |
| 88 | Acute myeloid leukemia (HP:0004808) | 2.28073622 |
| 89 | Abnormality of complement system (HP:0005339) | 2.27956825 |
| 90 | Erythema (HP:0010783) | 2.27940631 |
| 91 | Palmoplantar hyperkeratosis (HP:0000972) | 2.27232234 |
| 92 | Myopathic facies (HP:0002058) | 2.27062402 |
| 93 | Selective tooth agenesis (HP:0001592) | 2.27034801 |
| 94 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.25683919 |
| 95 | Hepatic necrosis (HP:0002605) | 2.25324361 |
| 96 | Lipoatrophy (HP:0100578) | 2.23788921 |
| 97 | Abnormality of oral frenula (HP:0000190) | 2.23503199 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 2.23011370 |
| 99 | Generalized aminoaciduria (HP:0002909) | 2.22902562 |
| 100 | Right ventricular cardiomyopathy (HP:0011663) | 2.22861787 |
| 101 | Round ear (HP:0100830) | 2.21937225 |
| 102 | Ankyloglossia (HP:0010296) | 2.21457478 |
| 103 | Sparse eyelashes (HP:0000653) | 2.19075759 |
| 104 | Ragged-red muscle fibers (HP:0003200) | 2.18579410 |
| 105 | Abnormality of nucleobase metabolism (HP:0010932) | 2.17776001 |
| 106 | Abnormality of chromosome stability (HP:0003220) | 2.17463183 |
| 107 | Panhypogammaglobulinemia (HP:0003139) | 2.17278500 |
| 108 | Urticaria (HP:0001025) | 2.16302491 |
| 109 | Multiple enchondromatosis (HP:0005701) | 2.14653938 |
| 110 | IgM deficiency (HP:0002850) | 2.13438894 |
| 111 | Ulnar deviation of the wrist (HP:0003049) | 2.12773603 |
| 112 | Increased muscle lipid content (HP:0009058) | 2.12390158 |
| 113 | Abnormality of macrophages (HP:0004311) | 2.11239725 |
| 114 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09377449 |
| 115 | Osteolytic defects of the hand bones (HP:0009699) | 2.09206461 |
| 116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09206461 |
| 117 | Thick nail (HP:0001805) | 2.08763552 |
| 118 | Delayed CNS myelination (HP:0002188) | 2.08472024 |
| 119 | Plantar hyperkeratosis (HP:0007556) | 2.08153703 |
| 120 | Abnormality of B cell number (HP:0010975) | 2.07461112 |
| 121 | Abnormality of glycolysis (HP:0004366) | 2.06628290 |
| 122 | Increased serum pyruvate (HP:0003542) | 2.06628290 |
| 123 | Increased purine levels (HP:0004368) | 2.06500615 |
| 124 | Hyperuricemia (HP:0002149) | 2.06500615 |
| 125 | Hepatosplenomegaly (HP:0001433) | 2.05583669 |
| 126 | Reticulocytopenia (HP:0001896) | 2.05407072 |
| 127 | Hyperglycemia (HP:0003074) | 2.05263756 |
| 128 | Hepatocellular carcinoma (HP:0001402) | 2.05146593 |
| 129 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.05131893 |
| 130 | Neonatal onset (HP:0003623) | 2.04579550 |
| 131 | Erythroderma (HP:0001019) | 2.04501407 |
| 132 | Absent phalangeal crease (HP:0006109) | 2.04373443 |
| 133 | Microvesicular hepatic steatosis (HP:0001414) | 2.04045310 |
| 134 | Viral hepatitis (HP:0006562) | 2.04031200 |
| 135 | Squamous cell carcinoma (HP:0002860) | 2.03094131 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 2.01402586 |
| 137 | Acute encephalopathy (HP:0006846) | 2.01176035 |
| 138 | Hypoglycemic seizures (HP:0002173) | 1.99924579 |
| 139 | T lymphocytopenia (HP:0005403) | 1.99657349 |
| 140 | Vomiting (HP:0002013) | 1.98744270 |
| 141 | Dilated cardiomyopathy (HP:0001644) | 1.97472651 |
| 142 | Vacuolated lymphocytes (HP:0001922) | 1.93939218 |
| 143 | Abnormal foot bone ossification (HP:0010675) | 1.92225207 |
| 144 | Recurrent skin infections (HP:0001581) | 1.92094927 |
| 145 | Oligomenorrhea (HP:0000876) | 1.89550985 |
| 146 | Agnosia (HP:0010524) | 1.89372906 |
| 147 | Embryonal renal neoplasm (HP:0011794) | 1.88738207 |
| 148 | Cutaneous melanoma (HP:0012056) | 1.87764295 |
| 149 | Skin ulcer (HP:0200042) | 1.87758119 |
| 150 | Amaurosis fugax (HP:0100576) | 1.87075476 |
| 151 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.86561415 |
| 152 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86501656 |
| 153 | Premature ovarian failure (HP:0008209) | 1.86396846 |
| 154 | Deep philtrum (HP:0002002) | 1.86299610 |
| 155 | Syringomyelia (HP:0003396) | 1.86100951 |
| 156 | Spinal cord lesions (HP:0100561) | 1.86100951 |
| 157 | Progressive external ophthalmoplegia (HP:0000590) | 1.85840212 |
| 158 | Combined immunodeficiency (HP:0005387) | 1.85002981 |
| 159 | Rhabdomyosarcoma (HP:0002859) | 1.84648417 |
| 160 | Lymphoma (HP:0002665) | 1.84614669 |
| 161 | Thrombocytosis (HP:0001894) | 1.84379031 |
| 162 | Osteomyelitis (HP:0002754) | 1.82573016 |
| 163 | Ectropion (HP:0000656) | 1.82328746 |
| 164 | Duodenal stenosis (HP:0100867) | 1.82115949 |
| 165 | Small intestinal stenosis (HP:0012848) | 1.82115949 |
| 166 | Poikiloderma (HP:0001029) | 1.78808101 |
| 167 | Entropion (HP:0000621) | 1.78684316 |
| 168 | Periodontitis (HP:0000704) | 1.78060823 |
| 169 | Colitis (HP:0002583) | 1.77998856 |
| 170 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76675057 |
| 171 | Obstructive lung disease (HP:0006536) | 1.76675057 |
| 172 | Blepharitis (HP:0000498) | 1.75366141 |
| 173 | Deviation of the thumb (HP:0009603) | 1.73635960 |
| 174 | Abnormality of T cells (HP:0002843) | 1.72837844 |
| 175 | Abnormality of the umbilical cord (HP:0010881) | 1.72395080 |
| 176 | Abnormality of the prostate (HP:0008775) | 1.71682024 |
| 177 | Abnormal lung lobation (HP:0002101) | 1.71303703 |
| 178 | Cellulitis (HP:0100658) | 1.70859388 |
| 179 | Abnormality of T cell physiology (HP:0011840) | 1.70779556 |
| 180 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.69949098 |
| 181 | Single umbilical artery (HP:0001195) | 1.69949098 |
| 182 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.69949098 |
| 183 | Abnormality of T cell number (HP:0011839) | 1.69757090 |
| 184 | Pallor (HP:0000980) | 1.69394215 |
| 185 | Orthostatic hypotension (HP:0001278) | 1.68393762 |
| 186 | Abnormality of the salivary glands (HP:0010286) | 1.67250997 |
| 187 | Inflammation of the large intestine (HP:0002037) | 1.66584744 |
| 188 | Granulocytopenia (HP:0001913) | 1.66351653 |
| 189 | Gastrointestinal inflammation (HP:0004386) | 1.66022700 |
| 190 | Medulloblastoma (HP:0002885) | 1.65977419 |
| 191 | Abnormal platelet volume (HP:0011876) | 1.65951844 |
| 192 | Pili torti (HP:0003777) | 1.65695193 |
| 193 | Recurrent fungal infections (HP:0002841) | 1.64664616 |
| 194 | Rough bone trabeculation (HP:0100670) | 1.64596283 |
| 195 | Micronodular cirrhosis (HP:0001413) | 1.63494570 |
| 196 | Reduced antithrombin III activity (HP:0001976) | 1.63378427 |
| 197 | Short middle phalanx of the 5th finger (HP:0004220) | 1.63056195 |
| 198 | Mediastinal lymphadenopathy (HP:0100721) | 1.62619897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.24441836 |
| 2 | OBSCN | 4.92889148 |
| 3 | TTN | 3.81234432 |
| 4 | TRIB3 | 3.77633268 |
| 5 | PKN2 | 3.74197042 |
| 6 | PHKG1 | 3.58878323 |
| 7 | PHKG2 | 3.58878323 |
| 8 | SCYL2 | 3.23775653 |
| 9 | BUB1 | 3.17646507 |
| 10 | PBK | 3.11000853 |
| 11 | EIF2AK3 | 3.10801756 |
| 12 | SIK1 | 3.06561208 |
| 13 | EIF2AK1 | 2.79417853 |
| 14 | TTK | 2.56158159 |
| 15 | CDC7 | 2.51074774 |
| 16 | PDK3 | 2.48555991 |
| 17 | PDK4 | 2.48555991 |
| 18 | SRPK1 | 2.38858488 |
| 19 | NEK1 | 2.36049329 |
| 20 | TSSK6 | 2.26393055 |
| 21 | ERN1 | 2.19631145 |
| 22 | BMPR2 | 2.16647521 |
| 23 | FLT3 | 2.06792331 |
| 24 | LMTK2 | 2.00849591 |
| 25 | NME2 | 1.97998981 |
| 26 | FGFR4 | 1.96659519 |
| 27 | MAP2K3 | 1.96539280 |
| 28 | PLK4 | 1.95225436 |
| 29 | PIK3CG | 1.88909702 |
| 30 | MAP3K12 | 1.88611640 |
| 31 | PINK1 | 1.77292638 |
| 32 | MAP2K4 | 1.68218870 |
| 33 | SMG1 | 1.64343742 |
| 34 | MST4 | 1.62436814 |
| 35 | RIPK4 | 1.62318931 |
| 36 | INSRR | 1.59810114 |
| 37 | MYLK | 1.58418720 |
| 38 | MAP3K7 | 1.58147495 |
| 39 | PIK3CA | 1.57651037 |
| 40 | MST1R | 1.54357880 |
| 41 | TESK2 | 1.48469117 |
| 42 | STK10 | 1.48021940 |
| 43 | BRSK2 | 1.47857978 |
| 44 | WEE1 | 1.43161269 |
| 45 | PAK4 | 1.39453416 |
| 46 | ZAK | 1.37939775 |
| 47 | RPS6KB2 | 1.33958116 |
| 48 | NEK9 | 1.27628860 |
| 49 | PDK2 | 1.24291125 |
| 50 | PRKAA2 | 1.23553834 |
| 51 | MAPK12 | 1.23303823 |
| 52 | NME1 | 1.22758702 |
| 53 | CDK6 | 1.21352411 |
| 54 | STK16 | 1.21138076 |
| 55 | RIPK1 | 1.20790726 |
| 56 | IRAK3 | 1.17501796 |
| 57 | MAP3K14 | 1.15845687 |
| 58 | TEC | 1.12794668 |
| 59 | MAPK11 | 1.12288449 |
| 60 | MAP3K8 | 1.11245221 |
| 61 | JAK3 | 1.10520462 |
| 62 | PTK6 | 1.09721159 |
| 63 | PLK3 | 1.08025295 |
| 64 | MAP3K6 | 1.05073436 |
| 65 | VRK2 | 1.04185340 |
| 66 | STK38L | 1.04176781 |
| 67 | STK24 | 1.03536960 |
| 68 | CLK1 | 1.02889106 |
| 69 | CDK4 | 1.02645630 |
| 70 | AURKB | 1.02468355 |
| 71 | CAMK1D | 1.01506060 |
| 72 | PRKAA1 | 0.99372969 |
| 73 | IRAK4 | 0.95555812 |
| 74 | CDK7 | 0.93805676 |
| 75 | BLK | 0.92121524 |
| 76 | MAP3K3 | 0.91447828 |
| 77 | MAP2K6 | 0.90847500 |
| 78 | TAF1 | 0.88956800 |
| 79 | PLK1 | 0.88818901 |
| 80 | TIE1 | 0.86414359 |
| 81 | FGR | 0.85347968 |
| 82 | CDK12 | 0.83403430 |
| 83 | MKNK1 | 0.83302077 |
| 84 | BTK | 0.82966169 |
| 85 | STK3 | 0.82500936 |
| 86 | CHEK2 | 0.82333085 |
| 87 | EIF2AK2 | 0.82115658 |
| 88 | PASK | 0.82074844 |
| 89 | STK4 | 0.80085625 |
| 90 | ATR | 0.79728797 |
| 91 | MAPKAPK3 | 0.77727409 |
| 92 | NUAK1 | 0.76382119 |
| 93 | ERBB4 | 0.73745945 |
| 94 | CSK | 0.73257271 |
| 95 | VRK1 | 0.71962305 |
| 96 | FES | 0.71828078 |
| 97 | NEK2 | 0.70787855 |
| 98 | RAF1 | 0.70642508 |
| 99 | SIK3 | 0.70002021 |
| 100 | ALK | 0.69745878 |
| 101 | YES1 | 0.68261544 |
| 102 | CCNB1 | 0.66431467 |
| 103 | DMPK | 0.65993015 |
| 104 | KDR | 0.65181989 |
| 105 | CHEK1 | 0.64923240 |
| 106 | MELK | 0.64532806 |
| 107 | MAP3K11 | 0.60933940 |
| 108 | BRD4 | 0.60458037 |
| 109 | ERBB3 | 0.60082782 |
| 110 | JAK2 | 0.59897746 |
| 111 | TAOK2 | 0.59871611 |
| 112 | RPS6KA4 | 0.59636311 |
| 113 | PDGFRA | 0.59142098 |
| 114 | RET | 0.58957367 |
| 115 | MAP3K5 | 0.58453270 |
| 116 | ILK | 0.58437441 |
| 117 | CAMK2G | 0.58436132 |
| 118 | PRPF4B | 0.57690866 |
| 119 | TYK2 | 0.57482017 |
| 120 | CAMK1G | 0.56918405 |
| 121 | LATS1 | 0.56442645 |
| 122 | MAP3K2 | 0.55723341 |
| 123 | PRKACG | 0.55707622 |
| 124 | TBK1 | 0.54775599 |
| 125 | KSR2 | 0.54519770 |
| 126 | PAK3 | 0.53827942 |
| 127 | TGFBR1 | 0.53488818 |
| 128 | ZAP70 | 0.52549841 |
| 129 | MAP2K1 | 0.52402143 |
| 130 | PDPK1 | 0.52113081 |
| 131 | MET | 0.51133464 |
| 132 | ITK | 0.51128457 |
| 133 | MUSK | 0.50463230 |
| 134 | ATM | 0.50385194 |
| 135 | TAOK3 | 0.49119820 |
| 136 | HCK | 0.48983299 |
| 137 | FGFR1 | 0.48912324 |
| 138 | JAK1 | 0.48253786 |
| 139 | MATK | 0.47309227 |
| 140 | AKT2 | 0.46757467 |
| 141 | AURKA | 0.45954882 |
| 142 | PDK1 | 0.44074933 |
| 143 | LATS2 | 0.43789157 |
| 144 | MAP3K13 | 0.41277210 |
| 145 | PRKD1 | 0.41014507 |
| 146 | EPHB1 | 0.40762682 |
| 147 | EPHA2 | 0.40296826 |
| 148 | ABL2 | 0.39496351 |
| 149 | CDK8 | 0.39338298 |
| 150 | PIM1 | 0.38943381 |
| 151 | FGFR3 | 0.38837130 |
| 152 | PRKG2 | 0.38194435 |
| 153 | FRK | 0.38187117 |
| 154 | LYN | 0.38075028 |
| 155 | ROCK1 | 0.37345611 |
| 156 | MAP3K10 | 0.37098422 |
| 157 | MAPK4 | 0.35777783 |
| 158 | SGK3 | 0.34422589 |
| 159 | LRRK2 | 0.33208466 |
| 160 | CAMK2D | 0.32972691 |
| 161 | BMX | 0.32966709 |
| 162 | EPHA3 | 0.30242487 |
| 163 | PRKACB | 0.30166491 |
| 164 | PRKD3 | 0.29722742 |
| 165 | MAP3K1 | 0.29452400 |
| 166 | FER | 0.29325513 |
| 167 | PTK2B | 0.28479538 |
| 168 | DAPK3 | 0.27250279 |
| 169 | PRKCZ | 0.26274641 |
| 170 | MTOR | 0.25908474 |
| 171 | EEF2K | 0.25068921 |
| 172 | PRKACA | 0.25034034 |
| 173 | TGFBR2 | 0.24716699 |
| 174 | PRKCH | 0.23651951 |
| 175 | STK38 | 0.23366971 |
| 176 | TRPM7 | 0.22514010 |
| 177 | LIMK1 | 0.22494108 |
| 178 | FGFR2 | 0.21725516 |
| 179 | GSK3A | 0.21636007 |
| 180 | ERBB2 | 0.20535227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.98507515 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.61202012 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.43535434 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.37963305 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.05601087 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.04766512 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.94333801 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.94273187 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.93265106 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.86997562 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80545371 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.79318069 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78733787 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.68535217 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.56155370 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54362805 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.49461134 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.41241284 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40901531 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38160803 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.32456318 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 2.18200232 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17975087 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 2.13718559 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.13206294 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06254766 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.05460600 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 2.03440683 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 2.00243830 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.99792998 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.98444605 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93391139 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.92214809 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.83276133 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.81171390 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.73417689 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63845221 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63724712 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63152893 |
| 40 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59484856 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52725476 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47253334 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47077872 |
| 44 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.45118454 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.43890141 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40771503 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40431919 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.38078082 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.36642465 |
| 50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.35021381 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33651298 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31479898 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31290246 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30819278 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25884743 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25623658 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 1.24729584 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22598580 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20716700 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19247355 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 1.18081605 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17564775 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.15916576 |
| 64 | Asthma_Homo sapiens_hsa05310 | 1.14583662 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13616237 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13281793 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11480855 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.10988743 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09282605 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08074883 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07488353 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07454465 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05489100 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04450467 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03519138 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03127139 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02782794 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02669736 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.98947968 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.97977500 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97504797 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.97104724 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96343732 |
| 84 | RNA degradation_Homo sapiens_hsa03018 | 0.95388203 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93597244 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91619979 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.90076035 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88696763 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.88213361 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.87943318 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87601163 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.86724929 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86444237 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.86313955 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86166861 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84605599 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83880878 |
| 98 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83451487 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81436967 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79332373 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78749080 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.78522336 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77933989 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77625879 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.77296508 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75424150 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75288962 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.74704827 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.74172858 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74109823 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72663964 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71973005 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71686184 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68793451 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68425556 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68244692 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.67995884 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67502658 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67436066 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67429125 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67353288 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66923620 |
| 123 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66863467 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66743568 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65134475 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64412645 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63956368 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63636384 |
| 129 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63626345 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63468971 |
| 131 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.62204565 |
| 132 | Protein export_Homo sapiens_hsa03060 | 0.61483425 |
| 133 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60520819 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60193845 |
| 135 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59267185 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59213242 |
| 137 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57708070 |
| 138 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57153973 |
| 139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56758539 |
| 140 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55800459 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53790063 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.51776827 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50467780 |
| 144 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49186970 |
| 145 | Malaria_Homo sapiens_hsa05144 | 0.48843529 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48245375 |
| 147 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47953840 |
| 148 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47366781 |
| 149 | Phagosome_Homo sapiens_hsa04145 | 0.47176038 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47046582 |
| 151 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46079840 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45481902 |
| 153 | Platelet activation_Homo sapiens_hsa04611 | 0.42372820 |
| 154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42334434 |
| 155 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41972121 |
| 156 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40651637 |
| 157 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39707935 |
| 158 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39433283 |
| 159 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38877144 |
| 160 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38827441 |
| 161 | Hepatitis C_Homo sapiens_hsa05160 | 0.37358128 |
| 162 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37053392 |
| 163 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22933238 |
| 164 | Prion diseases_Homo sapiens_hsa05020 | 0.13023848 |
| 165 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12478140 |
| 166 | Huntingtons disease_Homo sapiens_hsa05016 | 0.11276553 |
| 167 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10077195 |
| 168 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09486829 |
| 169 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.08477250 |
| 170 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07756981 |
| 171 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.04144099 |
| 172 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.03271483 |
| 173 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.01786658 |
| 174 | Amoebiasis_Homo sapiens_hsa05146 | -0.1273532 |
| 175 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0989675 |
| 176 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0872422 |
| 177 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | -0.0714514 |
| 178 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0497091 |
| 179 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0170163 |

